-
Something wrong with this record ?
Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry
O. Derner, A. Kramer, Z. Hruskova, M. Arici, F. Collart, P. Finne, L. Fuentes Sánchez, J. Harambat, MH. Hemmelder, K. Hommel, J. Kerschbaum, J. De Meester, R. Palsson, M. Segelmark, R. Skrunes, JP. Traynor, O. Zurriaga, ZA. Massy, KJ. Jager, VS....
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Kidney Failure, Chronic * epidemiology etiology therapy MeSH
- Incidence MeSH
- Humans MeSH
- Renal Replacement Therapy methods MeSH
- Lupus Nephritis * MeSH
- Registries MeSH
- Renal Insufficiency * complications MeSH
- Retrospective Studies MeSH
- Lupus Erythematosus, Systemic * complications epidemiology therapy MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
RATIONALE & OBJECTIVE: There is a dearth of data characterizing patients receiving kidney replacement therapy (KRT) for kidney failure due to systemic lupus erythematosus (SLE) and their clinical outcomes. The aim of this study was to describe trends in incidence and prevalence of KRT among these patients as well as to compare their outcomes versus those of patients treated with KRT for diseases other than SLE. STUDY DESIGN: Retrospective cohort study based on kidney registry data. SETTING & PARTICIPANTS: Patients recorded in 14 registries of patients receiving KRT that provided data to the European Renal Association Registry between 1992 and 2016. PREDICTOR: SLE as cause of kidney failure. OUTCOMES: Incidence and prevalence of KRT, patient survival while receiving KRT, patient and graft survival after kidney transplant, and specific causes of death. ANALYTICAL APPROACH: Kaplan-Meier methods and Cox regression models were fit to compare patient survival between the SLE and non-SLE groups, overall KRT, dialysis, and patient and graft survival after kidney transplant. RESULTS: In total, 1,826 patients commenced KRT for kidney failure due to SLE, representing an incidence of 0.80 per million population (pmp) per year. The incidence remained stable during the study period (annual percent change, 0.1% [95% CI, -0.6% to 0.8%]). Patient survival among patients with SLE receiving KRT was similar to survival in the comparator group (hazard ratio [HR], 1.11 [95% CI, 0.99-1.23]). After kidney transplant, the risk of death was greater among patients with SLE than among patients in the comparator group (HR, 1.25 [95% CI, 1.02-1.53]), whereas the risk of all-cause graft failure was similar (HR, 1.09 [95% CI, 0.95-1.27]). Ten-year patient overall survival during KRT and patient and graft survival after kidney transplant improved over the study period (HRs of 0.71 [95% CI, 0.56-0.91], 0.43 [95% CI, 0.27-0.69], and 0.60 [95% CI, 0.43-0.84], respectively). Patients with SLE receiving KRT were significantly more likely to die of infections (24.8%) than patients in the comparator group (16.9%; P < 0.001). LIMITATIONS: No data were available on extrarenal manifestations of SLE, drug treatments, comorbidities, kidney transplant characteristics, or relapses of SLE. CONCLUSIONS: The prognosis of patients with SLE receiving KRT has improved over time. Survival of patients with SLE who required KRT was similar compared with patients who required KRT for other causes of kidney failure. Survival following kidney transplants was worse among patients with SLE.
Abdominal Center Nephrology University of Helsinki and Helsinki University Hospital Helsinki Finland
Department of Clinical Medicine University of Bergen Bergen Norway
Department of Medicine Haukeland University Hospital Bergen Norway
Department of Medicine Holbaek Hospital Holbaek Denmark
Department of Nephrology Faculty of Medicine Hacettepe University Ankara Turkey
Department of Preventive Medicine and Public Health Universitat de Valencia Valencia Spain
Division of Nephrology Landspitali The National University Hospital of Iceland Reykjavik Iceland
Dutch Renal Registry Renine Nefrovisie Foundation Utrecht the Netherlands
Faculty of Medicine School of Health Sciences University of Iceland Reykjavik Iceland
Finnish Registry for Kidney Diseases Helsinki Finland
French Belgian ESRD Registry Brussels Belgium
Scottish Renal Registry Meredian Court Information Services Division Scotland Glasgow United Kingdom
Servicio Nefrologia Hospital Regional de Málaga Málaga Spain
Spanish Consortium for Research on Epidemiology and Public Health Madrid Spain
Valencia Region Renal Registry Direccio General de Salut Publica i Adiccions Valencia Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018500
- 003
- CZ-PrNML
- 005
- 20220804134819.0
- 007
- ta
- 008
- 220720s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1053/j.ajkd.2021.09.016 $2 doi
- 035 __
- $a (PubMed)34752912
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Derner, Ondrej $u Department of Nephrology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
- 245 10
- $a Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry / $c O. Derner, A. Kramer, Z. Hruskova, M. Arici, F. Collart, P. Finne, L. Fuentes Sánchez, J. Harambat, MH. Hemmelder, K. Hommel, J. Kerschbaum, J. De Meester, R. Palsson, M. Segelmark, R. Skrunes, JP. Traynor, O. Zurriaga, ZA. Massy, KJ. Jager, VS. Stel, V. Tesar
- 520 9_
- $a RATIONALE & OBJECTIVE: There is a dearth of data characterizing patients receiving kidney replacement therapy (KRT) for kidney failure due to systemic lupus erythematosus (SLE) and their clinical outcomes. The aim of this study was to describe trends in incidence and prevalence of KRT among these patients as well as to compare their outcomes versus those of patients treated with KRT for diseases other than SLE. STUDY DESIGN: Retrospective cohort study based on kidney registry data. SETTING & PARTICIPANTS: Patients recorded in 14 registries of patients receiving KRT that provided data to the European Renal Association Registry between 1992 and 2016. PREDICTOR: SLE as cause of kidney failure. OUTCOMES: Incidence and prevalence of KRT, patient survival while receiving KRT, patient and graft survival after kidney transplant, and specific causes of death. ANALYTICAL APPROACH: Kaplan-Meier methods and Cox regression models were fit to compare patient survival between the SLE and non-SLE groups, overall KRT, dialysis, and patient and graft survival after kidney transplant. RESULTS: In total, 1,826 patients commenced KRT for kidney failure due to SLE, representing an incidence of 0.80 per million population (pmp) per year. The incidence remained stable during the study period (annual percent change, 0.1% [95% CI, -0.6% to 0.8%]). Patient survival among patients with SLE receiving KRT was similar to survival in the comparator group (hazard ratio [HR], 1.11 [95% CI, 0.99-1.23]). After kidney transplant, the risk of death was greater among patients with SLE than among patients in the comparator group (HR, 1.25 [95% CI, 1.02-1.53]), whereas the risk of all-cause graft failure was similar (HR, 1.09 [95% CI, 0.95-1.27]). Ten-year patient overall survival during KRT and patient and graft survival after kidney transplant improved over the study period (HRs of 0.71 [95% CI, 0.56-0.91], 0.43 [95% CI, 0.27-0.69], and 0.60 [95% CI, 0.43-0.84], respectively). Patients with SLE receiving KRT were significantly more likely to die of infections (24.8%) than patients in the comparator group (16.9%; P < 0.001). LIMITATIONS: No data were available on extrarenal manifestations of SLE, drug treatments, comorbidities, kidney transplant characteristics, or relapses of SLE. CONCLUSIONS: The prognosis of patients with SLE receiving KRT has improved over time. Survival of patients with SLE who required KRT was similar compared with patients who required KRT for other causes of kidney failure. Survival following kidney transplants was worse among patients with SLE.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 12
- $a chronické selhání ledvin $x epidemiologie $x etiologie $x terapie $7 D007676
- 650 12
- $a systémový lupus erythematodes $x komplikace $x epidemiologie $x terapie $7 D008180
- 650 12
- $a nefritida při lupus erythematodes $7 D008181
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a registrace $7 D012042
- 650 12
- $a renální insuficience $x komplikace $7 D051437
- 650 _2
- $a náhrada funkce ledvin $x metody $7 D017582
- 650 _2
- $a retrospektivní studie $7 D012189
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kramer, Anneke $u ERA Registry, Amsterdam UMC, University of Amsterdam, Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands. Electronic address: a.kramer@amsterdamumc.nl
- 700 1_
- $a Hruskova, Zdenka $u Department of Nephrology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
- 700 1_
- $a Arici, Mustafa $u Department of Nephrology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
- 700 1_
- $a Collart, Frederic $u French-Belgian ESRD Registry, Brussels, Belgium
- 700 1_
- $a Finne, Patrik $u Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Finnish Registry for Kidney Diseases, Helsinki, Finland
- 700 1_
- $a Fuentes Sánchez, Laura $u Servicio Nefrologia, Hospital Regional de Málaga, Málaga, Spain
- 700 1_
- $a Harambat, Jérôme $u Unité de Néphrologie, Service de Pédiatrie, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Institut National de la Santé et de la Recherche Médicale (INSERM) U1219, Bordeaux, France
- 700 1_
- $a Hemmelder, Marc H $u Dutch Renal Registry Renine, Nefrovisie Foundation, Utrecht, the Netherlands; Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Center, Maastricht, The Netherlands
- 700 1_
- $a Hommel, Kristine $u Department of Medicine, Holbaek Hospital, Holbaek, Denmark
- 700 1_
- $a Kerschbaum, Julia $u Austrian Dialysis and Transplant Registry, Department of Internal Medicine IV-Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria
- 700 1_
- $a De Meester, Johan $u Department of Nephrology, Dialysis and Hypertension, Dutch-speaking Belgian Renal Registry, Sint-Niklaas, Belgium
- 700 1_
- $a Palsson, Runolfur $u Division of Nephrology, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland
- 700 1_
- $a Segelmark, Mårten $u Department of Clinical Sciences, Division of Nephrology, Lund University and Skane University Hospital, Lund, Sweden
- 700 1_
- $a Skrunes, Rannveig $u Department of Medicine, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway
- 700 1_
- $a Traynor, Jamie P $u Scottish Renal Registry, Meredian Court, Information Services Division Scotland, Glasgow, United Kingdom
- 700 1_
- $a Zurriaga, Oscar $u Valencia Region Renal Registry, Direccio General de Salut Publica i Adiccions, Valencia, Spain; Department of Preventive Medicine and Public Health, Universitat de Valencia, Valencia, Spain; Rare Diseases Joint Research Unit, Universitat de Valencia-Foundation for the Promotion of Health and Biomedical Research in the Valencian Region Renal Registry, FISABIO, Valencia, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain
- 700 1_
- $a Massy, Ziad A $u Division of Nephrology, Ambroise Paré University Hospital, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, Paris, France; INSERM Unit 1018 Team 5, Research Centre in Epidemiology and Population Health, University of Paris Ouest Versailles Saint-Quentin-en-Yveline, Villejuif, France
- 700 1_
- $a Jager, Kitty J $u ERA Registry, Amsterdam UMC, University of Amsterdam, Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands
- 700 1_
- $a Stel, Vianda S $u ERA Registry, Amsterdam UMC, University of Amsterdam, Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands
- 700 1_
- $a Tesar, Vladimir $u Department of Nephrology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
- 773 0_
- $w MED00000258 $t American journal of kidney diseases : the official journal of the National Kidney Foundation $x 1523-6838 $g Roč. 79, č. 5 (2022), s. 635-645
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34752912 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134812 $b ABA008
- 999 __
- $a ok $b bmc $g 1822200 $s 1169743
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 79 $c 5 $d 635-645 $e 20211106 $i 1523-6838 $m American journal of kidney diseases $n Am J Kidney Dis $x MED00000258
- LZP __
- $a Pubmed-20220720
